Shuichan Xu
About Shuichan Xu
Shuichan Xu is the Sr. Director of Molecular Pharmacology at the Oncogenesis Thematic Research Center for Bristol Myers Squibb in San Diego, California. With over 20 years of experience in molecular pharmacology and oncology research, Xu has held significant roles at Celgene, SGX Pharmaceuticals, and The Salk Institute.
Current Role at Bristol Myers Squibb
Shuichan Xu holds the position of Sr. Director, Molecular Pharmacology, at the Oncogenesis Thematic Research Center at Bristol Myers Squibb. Based in San Diego, California, she has been leading research in molecular pharmacology and oncogenesis since November 2019. In this capacity, Shuichan oversees critical research initiatives with a focus on cancer development and treatment.
Previous Experience at Celgene
Prior to joining Bristol Myers Squibb, Shuichan Xu served as Director at Celgene. She worked there for 17 years, from 2002 to 2019, significantly contributing to molecular pharmacology research. During her tenure, she played a key role in various research projects, helping to advance Celgene's mission in the biotech and pharmaceutical sectors.
Career at SGX Pharmaceuticals
Shuichan Xu worked at SGX Pharmaceuticals as a Scientist from 2000 to 2002. Her role involved working on cutting-edge biotechnology research in San Diego, California. During these two years, she contributed to pivotal scientific studies and gained valuable experience in the pharmaceutical industry.
Postdoctoral Fellowship at The Salk Institute
From 1997 to 2000, Shuichan Xu served as a Postdoctoral Fellow at The Salk Institute in San Diego, California. During her three-year fellowship, she conducted extensive research in molecular biology, furthering her expertise in this critical field. Her work at The Salk Institute solidified her foundation in scientific research and set the stage for her future contributions in pharmacology and oncology.
Educational Background in Molecular Biology and Pharmacy
Shuichan Xu achieved her Doctorate, specializing in Molecular Biology and Pharmacy, from 1986 to 1992. Additionally, she holds a Bachelor's degree from Wuhan University, where she studied Molecular Biology and Virology. Her strong academic background has been instrumental in shaping her proficiency in molecular pharmacology and oncology research.
Industry Experience in San Diego Biotechnology
With over 20 years of experience, Shuichan Xu has made significant contributions to the San Diego biotech and pharmaceutical industry. Her extensive background includes various research and leadership roles at esteemed institutions such as Bristol Myers Squibb, Celgene, SGX Pharmaceuticals, and The Salk Institute. Her deep-rooted experience in this region underscores her expertise in molecular pharmacology and oncology.